scispace - formally typeset
A

Anna Zorzet

Researcher at Uppsala University

Publications -  24
Citations -  4217

Anna Zorzet is an academic researcher from Uppsala University. The author has contributed to research in topics: Collective action & Sustainable development. The author has an hindex of 14, co-authored 24 publications receiving 2532 citations. Previous affiliations of Anna Zorzet include Royal Melbourne Hospital.

Papers
More filters
Journal ArticleDOI

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Evelina Tacconelli, +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI

Antimicrobial resistance—a threat to the world’s sustainable development

TL;DR: The paper stresses the need for greater international collaboration and accountability distribution, and suggests steps towards a broader engagement of countries and United Nations agencies to foster global intersectoral action on antimicrobial resistance.
Journal ArticleDOI

Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes

TL;DR: Resistance mutations were identified in two genes that are required for the formylation of methionyl (Met) initiator tRNA (tRNAi)(fMet), and these resistance mutations conferred a fitness cost that was manifested as a reduced growth rate in laboratory medium and in mice.
Journal ArticleDOI

International cooperation to improve access to and sustain effectiveness of antimicrobials

TL;DR: In this paper, the authors call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action for securing access to effective antimicrobials.
Journal ArticleDOI

An international legal framework to address antimicrobial resistance

TL;DR: The possible role that a binding international legal framework can play in the fight against antimicrobial resistance is outlined, which requires new coordination and financing mechanisms to be organized globally.